Goodroot Releases Guide for Healthcare Payers Weighing Coverage of Ozempic, Wegovy and Mounjaro
As breakthrough obesity drugs Ozempic and Wegovy rapidly gain in popularity, the free guide is designed to help healthcare payers make decisions on covering these high-cost medications.
- As breakthrough obesity drugs Ozempic and Wegovy rapidly gain in popularity, the free guide is designed to help healthcare payers make decisions on covering these high-cost medications.
- This guide compiles all of the available information to help payers make informed decisions."
- "In the private sector, the perception of obesity drug coverage is undergoing a shift," reads the guide.
- "Our mission at Goodroot is increasing access and affordability in healthcare," says Goodroot CEO Mike Waterbury.